Increase/Decrease in Cash: The total change in cash for the company over the given period.
Sagimet Biosciences Inc. (SGMT) had Increase/Decrease in Cash of $-40.82M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-9.57M |
|
-- |
|
-- |
|
$10.77M |
|
$-10.77M |
|
$1.20M |
|
$-9.57M |
|
$-9.57M |
|
$-9.57M |
|
$-9.57M |
|
$-9.57M |
|
$-9.57M |
|
$-10.77M |
|
$-10.46M |
|
32.35M |
|
32.35M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$116.40M |
|
-- |
|
$0.08M |
|
$116.48M |
|
$5.10M |
|
-- |
|
-- |
|
$5.10M |
|
$111.38M |
|
$111.38M |
|
$111.38M |
|
32.52M |
|
| Cash Flow Statement Financials | |
$-45.65M |
|
$4.56M |
|
$0.28M |
|
$75.84M |
|
$35.02M |
|
|
Increase/Decrease in Cash |
$-40.82M |
$6.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-45.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.59% |
|
-8.59% |
|
-8.21% |
|
-8.59% |
|
$3.42 |
|
$-1.41 |
|
$-1.41 |
|